GREM1 Is Required to Maintain Cellular Heterogeneity in Pancreatic Cancer

By
Danielle Corrigan
-
0
361
Researchers identified the BMP inhibitor GREM16,7 as a key regulator of cellular heterogeneity in pancreatic cancer in human and mouse.
[Nature]
Abstract